文献速递妇科生殖医学

DEAR模型在超重子宫内膜癌患者保留生育功能治疗中的随机对照试验

DEAR model in overweight endometrial cancer patients undergoing fertility-sparing treatment: A randomized controlled trial.
PubMed 文献 · Gynecol Oncol · 2024-02-28

本研究将接受保留生育功能治疗且BMI>25 kg/m2的子宫内膜癌或非典型增生患者随机分为DEAR体重管理组和对照组,每组36例。干预后DEAR组体重、BMI、脂质蓄积指数、体脂量、内脏脂肪面积及糖脂代谢指标(高密度脂蛋白除外)均显著低于对照组,完全缓解率显著更高(88.46% vs 57.14%),完全缓解时间无显著差异。

要点

  • DEAR体重管理可改善超重子宫内膜癌或非典型增生患者保留生育治疗期间的体重、体成分及糖脂代谢指标。
  • DEAR组完全缓解率显著高于对照组(88.46% vs 57.14%,P<0.05)。
  • 两组完全缓解时间无显著差异(P>0.05)。

核心结论

  • DEAR体重管理可改善该人群的体重、体成分、糖脂代谢指标及完全缓解率。

研究设计与样本

  • 随机对照试验,纳入接受保留生育功能治疗且BMI>25 kg/m2的子宫内膜癌或非典型增生女性,随机分为DEAR体重管理组和对照(自我体重管理)组,共72例(每组36例)。

主要发现

  • 干预后DEAR组中位体重为69.45 vs 对照组78.05,BMI为26.19 vs 29.15,脂质蓄积指数为29.21 vs 57.86,体脂量为24.00 vs 29.30,内脏脂肪面积为112.5 vs 133.3,糖脂代谢指标(高密度脂蛋白除外)均显著低于对照组(P<0.05),并呈下降趋势。
  • DEAR组完全缓解率显著高于对照组(88.46% vs 57.14%;P<0.05)。
  • 两组完全缓解时间无显著差异(P>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effects of DEAR weight management in overweight patients undergoing fertility-sparing treatment for endometrial cancer or atypical hyperplasia. METHODS: Women with endometrial cancer or atypical hyperplasia who received fertility-sparing treatment and had a body mass index of >25 kg/m2 were randomly allocated to the DEAR (DEAR weight management) and control (self weight management) groups. Body morphology and composition, glycolipid metabolism, and tumor outcomes were assessed in both groups before and at 3 and 6 months after intervention. RESULTS: Overall, 72 subjects were included (36 in each group). Following intervention, the DEAR group showed significantly lower median body weight (69.45 vs. 78.05), body mass index (26.19 vs. 29.15), lipid accumulation index (29.21 vs. 57.86), body fat mass (24.00 vs. 29.30), visceral fat area (112.5 vs. 133.3), and glycolipid metabolic indices (except high density lipoprotein) than the control group (P < 0.05) and showed a decreasing trend. The test group achieved significantly higher complete remission (88.46% vs. 57.14%; P < 0.05); the time to complete remission did not differ significantly (P > 0.05). CONCLUSIONS: DEAR weight management can improve the studied parameters and complete remission rates in this population. REGISTRATION: NCT06169449.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Yang J, Wan Y, et al. DEAR model in overweight endometrial cancer patients undergoing fertility-sparing treatment: A randomized controlled trial. Gynecol Oncol. 2024. PMID: 38422947. doi:10.1016/j.ygyno.2024.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。